
Malswift 40mg Injection
Marketer
Ind Swift Laboratories Ltd
Salt Composition
Chloroquine (40mg)
Overview Malswift 40mg Injection
Artemether 40mg Injection combats malaria parasites, preventing and treating the disease. Its mechanism involves eliminating the malaria-causing organism, halting infection spread. Administration is strictly by a healthcare provider via injection; self-administration is prohibited. Prevent mosquito bites using repellents on exposed skin, and spray indoor spaces to eliminate any mosquitoes. Wear light-colored, protective clothing outdoors after dusk. Possible side effects include weakness, nausea, vomiting, rash, and itching. Gastrointestinal upset (diarrhea, stomach pain, appetite loss) may also occur. Injection site reactions such as pain, swelling, or redness are possible. Persistent side effects require medical consultation. Diabetic patients should inform their physician, as the medication can lower blood sugar; regular monitoring is crucial. Blurred vision may occur, necessitating regular eye exams during treatment. Long-term use may necessitate regular blood tests to monitor blood cell counts. Report unexplained bruising or bleeding, sore throat, fever, or fatigue to your doctor immediately.
Uses of Malswift 40mg Injection
Managing Malaria Infection
Major Benefits of Malswift 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Malswift 40mg Injection:
- Weakness
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Malswift 40mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Malswift 40mg Injection works:
Malaria is effectively combated by the antiparasitic drug Malswift 40mg Injection. Its mechanism involves elevating blood haem levels, a process toxic to the malaria parasite, thereby eliminating the parasite and halting the infection's progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Malswift 40mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Malswift 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Malswift, at a 40mg dose, presents no known breastfeeding contraindications. Research in humans indicates negligible transfer of the drug into breast milk, posing minimal risk to the infant.
DrivingUNSAFE
Administering Malswift 40mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include blurred vision or impaired visual focus, potentially hindering safe operation of a vehicle.
KidneyCAUTION
Exercise caution when administering Malswift 40mg Injection to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Administering Malswift 40mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Malswift 40mg Injection might be necessary. Physician consultation is recommended. Routine assessment of liver function is advisable during treatment.
What if you forget to take Malswift 40mg Injection :
NA
Facts to Know About Malswift 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | 4-Aminoquinoline analog |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Aminoquinoline antimalarials |
